UCI clinical trials leader named ‘Giant of Cancer Care’
Dr. Susan M. O’Brien, the UCI Chao Family Comprehensive Cancer Center’s associate director for clinical research, has been named a Giant of Cancer Care® for her sustained contributions in the field of leukemia.
New study points to better diagnostics for cancer
A new University of California, Irvine-led study finds a new method for identifying biomarkers may aid in early cancer diagnosis. The study focused on lung cancer, however the Cell Heterogeneity-Adjusted cLonal Methylation (CHALM) method has been tested on aging and Alzheimer’s diseases as well and is expected to be effective for studying other diseases.
Virtual town hall addresses COVID-19 vaccine concerns in O.C.’s Asian American community
The OC Asian Pacific Islander Taskforce, along with the healthcare agency and UCI Cancer Center, hosted the town hall to address concerns in the Asian American and Pacific Islander community about vaccine side effects and distribution plans.
Cancer treatment without side effects?
Charles Limoli, professor of radiation oncology at UCI, and Marie-Catherine Vozenin, associate professor of radiation oncology at CHUV/UNIL, used an ultra-high dose rate of radiation therapy to eliminate brain tumors in mice, bypassing key side effects usually caused by cranial irradiation. Their findings are published in Clinical Cancer Research.
UCI study points to how skin cells cooperate to thwart cancer
Melanoma is a life-threatening skin cancer that spreads quickly to other organs if not treated early. A new discovery by University of California, Irvine biologists shatters traditional beliefs about how melanomas develop, providing new insights into fighting the disease. The scientists’ research appears in eLife.
UCI researchers use deep learning to identify gene regulation at single-cell level
Deep learning, a family of machine-learning methods based on artificial neural networks, has revolutionized applications such as image interpretation, natural language processing and autonomous driving. In a study published recently in Science Advances, UCI researchers describe how the technique can also be successfully used to observe gene regulation at the cellular level. Until now, that process had been limited to tissue-level analysis.
Heart disease, cancer and COVID-19: Orange County’s leading causes of death in 2020
For all the ways life in Orange County changed last year, many deaths were morbidly predictable: Heart disease and cancer, like years past, were the first and second leading killer diseases in 2020.
Radioactive bone cement found to be safer in treating spinal tumors
Lead researcher Joyce Keyak, UCI professor of radiological sciences, presented the results at the 2021 annual meeting of the Orthopaedic Research Society, which was held virtually Feb. 12-16. Cancers that begin in the breast, prostate, lung, thyroid, kidney and other locations can spread to and erode bones, most commonly in the spine. Further complicating matters, normal radiation treatments for this problem can threaten the spinal cord and weaken the bones already compromised by the tumor’s erosion, increasing the risk of fracture.
UCI to build world-class hospital on Irvine campus
The hospital joins the previously approved UCI Health Center for Advanced Care to create the new UCI Medical Center Irvine-Newport, a full-service academic health complex that will bring a broad spectrum of the most advanced healthcare services to coastal and southern Orange County, including access to the hundreds of clinical trials underway at UCI Health. The medical center will connect with the UCI Health primary care network throughout Orange County, including its newest clinic in Newport Beach, creating the region’s only health system supported by one of the nation’s premier academic research institutions.
Chao Lectureship: Past Speakers
CHAO LECTURESHIP SERIES: PAST SPEAKERS
The Chao Family Comprehensive Cancer Center is led by a Director, a Deputy Director, and a team of Associate Directors representing all aspects of the center.
The Chao Family Comprehensive Cancer Center brings together the expertise of external advisors who are leaders and content experts in their respective scientific, business and lay communities. Together, these boards guide the Cancer Center on their mission and vision.
The catchment area of the UCI Chao Family Comprehensive Cancer Center (CFCCC) is Orange County, California, which is the sixth-most populated county in the U.S. and a majority-minority county. CFCCC focuses our basic and clinical research on addressing burdens that affect Orange County.
Clinical trials are research studies to evaluate new drugs or devices aimed to improve treatments and the quality of life of patients. These trials are designed to test novel ways of treating cancer, finding and diagnosing cancer, preventing cancer, and managing side effects and other symptoms due to cancer. Clinical trials are the final step in a long process that begins with research in a lab. Clinical trials are the foundation of cancer screening, treatment and supportive care, allowing patients to receive the newest and most promising therapies.
At the UCI Chao Family Comprehensive Cancer Center (CFCCC), we offer a wide range of specialized treatment options to our patients. As the only National Cancer Institute designated comprehensive cancer center in Orange County, our patients have access to latest therapies through our most innovative clinical trials, many of them developed by CFCCC members.
Find a Location
Find a UCI Health location near you. Top-quality physicians and cancer care services are conveniently located throughout the region.
Cancer Support and Survivorship Services focuses on treating the whole patient, providing assistance with symptom management, supportive care and survivorship planning.